Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity

Archives of Biochemistry and Biophysics
S T OlsonG Zettlmeissl

Abstract

Two major glycoforms of recombinant antithrombin which differ 10-fold in their affinity for the effector glycosaminoglycan, heparin, were previously shown to be expressed in BHK or CHO mammalian cell lines (I. Björk, et al., 1992, Biochem. J. 286, 793-800; B. Fan et al., 1993, J. Biol. Chem. 268, 17588-17596). To determine the source of the glycosylation heterogeneity responsible for these different heparin-affinity forms, each of the four Asn residue sites of glycosylation, residues 96, 135, 155, and 192, was mutated to Gln to block glycosylation at these sites. Heparin-agarose chromatography of the four antithrombin variants revealed that Gln 96, Gln 135, and Gln 192 variants still displayed the two functional heparin-affinity forms previously observed with the wild-type inhibitor, whereas the Gln 155 variant showed only a single functional high heparin affinity form. These results demonstrate that heterogeneous glycosylation of Asn 155 of recombinant antithrombin is responsible for generating the low heparin affinity glycoform. Analysis of heparin binding to the higher heparin affinity forms of the four variants showed that all exhibited increased heparin affinities of two- to sevenfold compared to wild-type higher heparin a...Continue Reading

References

Aug 15, 1977·European Journal of Biochemistry·B NordenmanI Björk
Sep 15, 1978·European Journal of Biochemistry·B NordenmanI Björk
Sep 15, 1992·The Biochemical Journal·I BjörkG Zettlmeissl
Oct 10, 1991·Nature·R W CarrellP E Stein
Jan 1, 1985·Annual Review of Biochemistry·R Kornfeld, S Kornfeld
Dec 20, 1982·Nucleic Acids Research·S C BockR M Lawn
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D H AthaR D Rosenberg
Mar 1, 1982·Carbohydrate Research·L ThunbergU Lindahl
Jul 1, 1994·Nature Structural Biology·C A van BoeckelA Visser
Jan 1, 1994·Seminars in Thrombosis and Hemostasis·S T Olson, I Björk
Apr 15, 1994·Structure·R W CarrellM R Wardell

❮ Previous
Next ❯

Citations

Sep 8, 1999·The Biochemical Journal·D B BrimacombeC J Bostock
Jun 10, 2010·Expert Opinion on Biological Therapy·Nirvik PalMichael S Avidan
Sep 1, 2005·Journal of Thrombosis and Haemostasis : JTH·K Hansson, J Stenflo
May 16, 2014·Journal of Thrombosis and Haemostasis : JTH·S AguilaI Martínez-Martínez
Sep 19, 2003·Biochemical and Biophysical Research Communications·Anthony K C ChanNagina Parmar
Jun 4, 2015·The International Journal of Biochemistry & Cell Biology·Aysim GunesNese Atabey
Dec 5, 2000·Baillière's Best Practice & Research. Clinical Haematology·T J Lynch
May 24, 2016·Journal of Thrombosis and Haemostasis : JTH·M E de la Morena-BarrioV Vicente
Jan 6, 2004·Medicinal Research Reviews·Umesh R Desai
Aug 31, 2011·Journal of Biomolecular Structure & Dynamics·Poonam SinghMohamad Aman Jairajpuri
Apr 15, 2000·The Journal of Biological Chemistry·U DesaiS T Olson
May 1, 2002·Anesthesiology·Jerrold H LevyAndrew Weisinger
Aug 20, 2019·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Yuki YagiKatsuyoshi Yamazaki
Feb 8, 2000·The Journal of Biological Chemistry·A Futamura, P G Gettins
Dec 18, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Hiromitsu Kuroda, Yoshiki Masuda
May 11, 2021·Computational and Structural Biotechnology Journal·Zachariah P SchuursNeha S Gandhi
Jul 15, 2005·Journal of Chromatography. a·Uwe M DemelbauerAndreas Rizzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.